Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor.

Bendrat K, Fritz P, Müller S, Brockmöller S, Debus A, Friedrichs K, Lindner C, Brinkmann F, Heidemann E, Niendorf A.

Anticancer Res. 2016 Aug;36(8):3855-63.

PMID:
27466487
2.

Comparative metabolomics of estrogen receptor positive and estrogen receptor negative breast cancer: alterations in glutamine and beta-alanine metabolism.

Budczies J, Brockmöller SF, Müller BM, Barupal DK, Richter-Ehrenstein C, Kleine-Tebbe A, Griffin JL, Orešič M, Dietel M, Denkert C, Fiehn O.

J Proteomics. 2013 Dec 6;94:279-88. doi: 10.1016/j.jprot.2013.10.002. Epub 2013 Oct 11.

PMID:
24125731
3.

A difficult nasogastric tube in a patient with nephrogenic systemic fibrosis.

Vollnberg B, Knebel F, Böhm M, Brockmöller S, Dewey M.

Rofo. 2013 Sep;185(9):877-8. doi: 10.1055/s-0033-1335918. Epub 2013 Jul 15. No abstract available.

PMID:
23857072
4.

Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue - a GC-TOFMS based metabolomics study.

Budczies J, Denkert C, Müller BM, Brockmöller SF, Klauschen F, Györffy B, Dietel M, Richter-Ehrenstein C, Marten U, Salek RM, Griffin JL, Hilvo M, Orešič M, Wohlgemuth G, Fiehn O.

BMC Genomics. 2012 Jul 23;13:334. doi: 10.1186/1471-2164-13-334.

5.

Metabolomics of human breast cancer: new approaches for tumor typing and biomarker discovery.

Denkert C, Bucher E, Hilvo M, Salek R, Orešič M, Griffin J, Brockmöller S, Klauschen F, Loibl S, Barupal DK, Budczies J, Iljin K, Nekljudova V, Fiehn O.

Genome Med. 2012 Apr 30;4(4):37.

6.

Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling.

Brockmöller SF, Bucher E, Müller BM, Budczies J, Hilvo M, Griffin JL, Orešič M, Kallioniemi O, Iljin K, Loibl S, Darb-Esfahani S, Sinn BV, Klauschen F, Prinzler J, Bangemann N, Ismaeel F, Fiehn O, Dietel M, Denkert C.

J Proteome Res. 2012 Feb 3;11(2):850-60. doi: 10.1021/pr200685r. Epub 2011 Dec 15.

PMID:
22070544
7.

Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression.

Hilvo M, Denkert C, Lehtinen L, Müller B, Brockmöller S, Seppänen-Laakso T, Budczies J, Bucher E, Yetukuri L, Castillo S, Berg E, Nygren H, Sysi-Aho M, Griffin JL, Fiehn O, Loibl S, Richter-Ehrenstein C, Radke C, Hyötyläinen T, Kallioniemi O, Iljin K, Oresic M.

Cancer Res. 2011 May 1;71(9):3236-45. doi: 10.1158/0008-5472.CAN-10-3894. Epub 2011 Mar 17.

8.

[The trend distribution quotient, a new tool for evaluating renal perfusion scintigraphy using 99mTc-DTPA following renal transplantation].

Kittner C, Esther G, Finck W, Bast R, Templin R, Nizze H, Brockmöller S.

Nuklearmedizin. 1993 Feb;32(1):37-41. German.

PMID:
8464759
9.

[Infectious causes of death in renal transplant patients. A clinical pathological autopsy study].

Nizze H, Brockmöller S, Bast R, Schmitt E.

Verh Dtsch Ges Pathol. 1991;75:218-23. German.

PMID:
1724837
10.

[Pathology of the transplanted kidney and basic renal disease of the recipient].

Nizze H, Brockmöller S, Templin R.

Z Urol Nephrol. 1989 Jan;82(1):27-33. German.

PMID:
2652942
11.

[Kidney transplant rejection and the original kidney disease of the recipient].

Nizze H, Brockmöller S.

Verh Dtsch Ges Pathol. 1989;73:233-7. German.

PMID:
2482607
12.

[Dissecatio profunda ventriculi as an uncommon complication of necrotizing pancreatitis (author's transl)].

Putzke HP, Brockmöller S.

Zentralbl Allg Pathol. 1976;120(6):478-80. German.

PMID:
1087794

Supplemental Content

Loading ...
Support Center